17 Jul 2023 by admin in UncategorizedComments Alebund Achieved First Patient Enrolment for AP301 Pivotal Phase 3 Clinical Trial and Successfully Held Investigator Meeting in Beijing
11 Jul 2023 by admin in UncategorizedComments Adicet Announces Appointment of Katie Peng to the Board of Directors
16 May 2023 by admin in UncategorizedComments Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB- 301) Program to Treat Corneal Blindness
09 May 2023 by admin in UncategorizedComments Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
27 Apr 2023 by admin in UncategorizedComments Crescendo Biologics appoints Angus Hone as Chief Financial Officer
12 Apr 2023 by admin in UncategorizedComments Alebund Pharmaceuticals Closes Nearly RMB 200 Million Pre-C Round Financing and Secures RMB 800 Million Syndicated Loan Credit
